SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the return of "OG Memes" and 2021 vibes, fueled by bullish sentiment following recent market events. Community members are actively promoting its strong community, potential exchange listings, and the revival of Rage Comics, emphasizing the importance of conviction and bag-working in the current market. Discussions also focus on onboarding 1 million users to crypto via their community.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its community-driven approach and its connection to cannabis culture on the Solana blockchain. Community members are emphasizing its long-term vision, focus on positivity, and its potential within the emerging cannabis industry. Some users are drawing parallels to Bitcoin, emphasizing Weedcoin's potential for growth.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY is trending as community members rally around its strong cult following and meme-driven identity on the Solana blockchain. Despite market volatility, the community emphasizes their conviction and dedication to building a lasting presence. Discussions highlight the potential for significant growth and the unique culture surrounding $LENNY.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as it nears all-time highs, fueled by optimism around its robotaxi strategy and potential battery expansion in Europe. Community discussions revolve around the stock's valuation, potential short squeezes, and comparisons to competitors like Waymo, with some questioning the sustainability of the rally. Bullish sentiment remains strong, while bears cite concerns about sales figures and regulatory hurdles, such as California's Autopilot marketing scrutiny.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid speculation that the US cannabis sector is nearing a potential rescheduling event, possibly driven by an executive order. Community members are actively discussing the potential impact on US cannabis companies, including potential tax benefits and increased institutional investment. The ETF's price action reflects the current optimism surrounding the potential catalyst.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as investors anticipate earnings, driven by rising DRAM prices and AI-fueled demand, with analysts increasing price targets. Community members are weighing potential volatility after earnings, drawing comparisons to recent reactions to earnings from other AI-related stocks like AVGO and ORCL. Bullish sentiment surrounds MU's position as a key player in the memory sector, particularly with increasing memory prices and potential supply shortages.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors analyze its strategic shift towards weight loss drugs after recent dealmaking, with community discussions focusing on the potential valuation upside if the company successfully delivers an oral GLP-1 pill. A large short interest adds squeeze potential should positive clinical data emerge, while some traders are eyeing actionable trade alerts and call options. However, a lowered 2025 revenue outlook has tempered enthusiasm, leading to debates about management and the stock's long-term prospects.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending following positive registrational phase II study results for its CAR T therapy in stiff person syndrome, with analysts raising target prices. Community members are actively discussing the potential for a bidding war or buyout, along with the possibility of a marketed secondary offering. The surge in price and volume has traders weighing whether this is a biotech breakout or just the beginning.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the community discusses its potential role in upcoming AI infrastructure, particularly regarding power efficiency and data transfer bottlenecks. Chatter revolves around potential purchase orders and updates following a recent capital raise, with some anticipating news before the holidays.  The stock's tight coil and low float are also fueling speculation about a potential breakout.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

ARBK is trending amid discussions of a potential short squeeze and its low float, with some traders drawing comparisons to other high-flying stocks. Community members are also closely watching its relationship with Bitcoin's movements. The stock's volatility, reverse split, and restructuring are key points of conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Palvella Therapeutics (NASDAQ:PVLA) Trading Up 6.6% on Analyst Upgrade

Palvella Therapeutics (NASDAQ:PVLA) Trading 6.6% Higher on Analyst Upgrade...

TD Cowen Increases Palvella Therapeutics (NASDAQ:PVLA) Price Target to $133.00

TD Cowen lifted their price target on Palvella Therapeutics from $97.00 to $133.00 and gave the company a "buy" rating in a report on Tuesday...

XTX Topco Ltd Acquires Shares of 17,701 Palvella Therapeutics, Inc. $PVLA

XTX Topco Ltd bought a new stake in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Palvella Therapeutics (NASDAQ:PVLA) Trading 8% Higher - Still a Buy?

Palvella Therapeutics (NASDAQ:PVLA) Stock Price Up 8% - Here's What Happened...

Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 7.9% - Should You Sell?

Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 7.9% - Here's What Happened...

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) have earned an average recommendation of "Buy" from the thirteen brokerages that are currently covering the stock, Marketbeat...

Palvella Therapeutics, Inc. $PVLA Stake Reduced by Adams Street Partners LLC

Adams Street Partners LLC lowered its stake in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 27.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund...

Palvella Therapeutics (NASDAQ:PVLA) Stock Price Up 7.9% - Should You Buy?

Palvella Therapeutics (NASDAQ:PVLA) Trading Up 7.9% - Time to Buy...

Insider Selling: Palvella Therapeutics (NASDAQ:PVLA) COO Sells 4,302 Shares of Stock

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) COO Kathleen Goin sold 4,302 shares of the stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price...

Kathleen Goin Sells 4,302 Shares of Palvella Therapeutics (NASDAQ:PVLA) Stock

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) COO Kathleen Goin sold 4,302 shares of the business's stock in a transaction dated Wednesday, November 19th. The stock was sold at an...

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Palvella Therapeutics Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$96.81
Prev Close	$88.98
Open	$90.01
Dividend Yield	0.00%
50-Day Moving Average	$83.76
Beta	0.96
Avg. Volume	267,857.84
PE Ratio	-7.68

52-Week High	$112.00
52-Week Low	$11.17
Market Capitalization	$1.05B
EPS (Annual)	-$7.83
Price to Book	27.75
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PVLA
Palvella Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PVLA News

PVLAPalvella Therapeutics Inc